CenterWatch Monthly December 2008

Friday, December 5, 2008 11:15 AM

Demand for Medical Writing Continues to Rise

According to CenterWatch analysis, the medical writing market has more than doubled in size during the past five years, increasing from an estimated $345 million in 2003 to $694 million in 2008.

Making the Business Case for Accreditation

When the Association for the Accreditation of Human Research Protection Programs (AAHRPP) launched in 2001, its first accredited organizations comprised a few market segments. Today, AAHRPP has accredited 138 parent organizations, representing more than 600 entities from almost every type of human research organization.

Conditional and Accelerated Approach No Easy Route to Market Success

The accelerated and conditional approval processes are coming under close scrutiny in Europe, raising the possibility of a shake-up in how priority drugs are regulated over the coming months. One casualty could be the randomized clinical trial’s position as the “gold standard” of evidence in assessing drug efficacy.

Eye On: Juvenile Arthritis

Juvenile arthritis (JA), which is any type of arthritis or arthritis-related condition in young people under 18 years of age, affects approximately 294,000 children in the United States, according to the Arthritis Foundation. Typical symptoms are joint pain, swelling, tenderness and stiffness, which must be confirmed by physical examination. Ultimately, JA may progress to cause restricted range of motion, contracture, damage, deformity and/or altered growth of affected joints.

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick here

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs